AMLX·03237H101·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AMLX (AMYLYX PHARMACEUTICALS INC) is held by 92 institutional investors as of Q1 2026. Largest holders: FMR LLC ($231.2M), BlackRock, Inc. ($122.7M), JANUS HENDERSON GROUP PLC ($69.3M). Net institutional sentiment: Mixed.
See how AMLX's score breaks down across 4 SEC sources
Showing 1-20 of 108
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer